Search

Your search keyword '"Stephane Daffis"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Stephane Daffis" Remove constraint Author: "Stephane Daffis" Topic medicine Remove constraint Topic: medicine
31 results on '"Stephane Daffis"'

Search Results

1. Immunotherapeutic Strategies as Potential Treatment Options for Cutaneous Leishmaniasis

2. The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection.

3. Therapeutic Potential of TLR8 Agonist GS‐9688 (Selgantolimod) in Chronic Hepatitis B: Remodeling of Antiviral and Regulatory Mediators

4. Toll‐Like Receptor 8 Agonist GS‐9688 Induces Sustained Efficacy in the Woodchuck Model of Chronic Hepatitis B

5. Anti-HBV response to toll-like receptor 7 agonist GS-9620 is associated with intrahepatic aggregates of T cells and B cells

6. Double Lock of a Human Neutralizing and Protective Monoclonal Antibody Targeting the Yellow Fever Virus Envelope

7. Toll-like receptor 7 agonist GS-9620 induces prolonged inhibition of HBV via a type I interferon-dependent mechanism

9. Sustained efficacy and surface antigen seroconversion in the woodchuck model of chronic hepatitis B with the selective toll-like receptor 8 agonist GS-9688

10. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members

11. Cytokine-dependent activation of MAIT cells by the TLR8 agonist GS-9688 but not the TLR7 agonist GS-9620

13. Toll-Like Receptor 3 Has a Protective Role against West Nile Virus Infection

14. Reproductive Characteristics ofMastomys natalensisand Lassa Virus Prevalence in Guinea, West Africa

15. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants

16. The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection

17. In vitro and in vivo characterization of the selective toll-like receptor 8 agonist GS-9688

18. Sustained efficacy and seroconversion with the Toll-like receptor 7 agonist GS-9620 in the Woodchuck model of chronic hepatitis B

19. West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response

20. A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection

21. Interferon Regulatory Factor-1 (IRF-1) Shapes Both Innate and CD8+ T Cell Immune Responses against West Nile Virus Infection

22. The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response

23. IPS-1 Is Essential for the Control of West Nile Virus Infection and Immunity

24. The early protective innate immune response against West Nile virus

25. Fluctuation of abundance and Lassa virus prevalence in Mastomys natalensis in Guinea, West Africa

26. Mastomys natalensis and Lassa fever, West Africa

27. Genetic identification of Kodoro virus, a novel arenavirus of the African pigmy mouse (Mus Nannomys minutoides) in West Africa

28. The role of myristoylation in the membrane association of the Lassa virus matrix protein Z

29. Activation of the cytokine network and unfavorable outcome in patients with yellow fever

30. Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms

31. Mastomys natalensis and Lassa Fever, West Africa

Catalog

Books, media, physical & digital resources